| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |